Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Approves $400K Grant to Help BioForce Develop Surface Patterning Tool

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has approved $400,000 in funding for BioForce Nanosciences to help the company in the second commercial development phase of its surface patterning tools, BioForce said today.
 
SPT molecular ink cartridges are used in the company's core Nano eNabler benchtop molecular printing system.
 
"The next phase of our SPT cartridge development program focuses on the improvement and expansion of the capabilities and throughput of the devices," Curtis Mosher, vice president of R&D at BioForce, said in a statement. "SPT cartridge loading and cleaning in place are primary objectives of the ongoing program."
 
The company said that when the SPT portfolio is complete, customers “should be able to print spots, lines and complex paths of one or many different molecules or compounds."
 
The funding includes the “potential” for an additional $400,000 after Aug. 31, 2007, BioForce said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more